Eton Pharmaceuticals, Inc. (ETON) free cash flow
Eton Pharmaceuticals, Inc. (ETON) generated free cash flow of $10.19M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$9.05M. Figures as of 18 Nov 2026, 12:21 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Free cash flow, fiscal 2025
- $10.19M
- Highest on record
- $10.19Mfiscal 2025
- Lowest on record
- -$22.40Mfiscal 2020
- Fiscal years on record
- 82018–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Eton Pharmaceuticals, Inc. free cash flow, in more detail
Across the 8 fiscal years on record (2018–2025), the highest was $10.19M in fiscal 2025 and the lowest -$22.40M in fiscal 2020.
Free cash flow by fiscal year
Eton Pharmaceuticals, Inc. free cash flow, year by year
| Fiscal year | Free cash flow | Change | Year ended |
|---|---|---|---|
| 2025 | $10.19M | — | |
| 2024 | -$9.05M | 249.8% down | |
| 2023 | $6.04M | 197.1% up | |
| 2022 | $2.03M | — | |
| 2021 | -$4.73M | — | |
| 2020 | -$22.40M | — | |
| 2019 | -$19.12M | — | |
| 2018 | -$8.38M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.
How to read it
It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.
Eton Pharmaceuticals, Inc., figure by figure
- Eton Pharmaceuticals, Inc. market cap
- Eton Pharmaceuticals, Inc. revenue
- Eton Pharmaceuticals, Inc. earnings
- Eton Pharmaceuticals, Inc. earnings per share (EPS)
- Eton Pharmaceuticals, Inc. P/E ratio
- Eton Pharmaceuticals, Inc. P/S ratio
- Eton Pharmaceuticals, Inc. P/B ratio
- Eton Pharmaceuticals, Inc. operating margin
- Eton Pharmaceuticals, Inc. dividend
- Eton Pharmaceuticals, Inc. shares outstanding
- Eton Pharmaceuticals, Inc. total debt
- Eton Pharmaceuticals, Inc. cash on hand
- Eton Pharmaceuticals, Inc. total assets
- Eton Pharmaceuticals, Inc. return on equity (ROE)
- Eton Pharmaceuticals, Inc. return on invested capital (ROIC)
Eton Pharmaceuticals, Inc. (ETON) overview: price, valuation and scorecard
Eton Pharmaceuticals, Inc. free cash flow: questions and answers
What is Eton Pharmaceuticals, Inc.'s free cash flow?
Eton Pharmaceuticals, Inc. (ETON) generated free cash flow of $10.19M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$9.05M.
What are the highest and lowest free cash flow figures on record for Eton Pharmaceuticals, Inc.?
Across the 8 fiscal years on record (2018–2025), the highest was $10.19M in fiscal 2025 and the lowest -$22.40M in fiscal 2020.
How is Eton Pharmaceuticals, Inc.'s free cash flow calculated?
Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Eton Pharmaceuticals, Inc. it is on record here for 8 fiscal years, 2018 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: free cash flow
All stocks guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How a DCF valuation works, and why inputs swing it
A discounted cash flow (DCF) valuation estimates what a business is worth today by forecasting the cash it will produce and discounting each year's cash back at a required rate of return. Because most of the value lies far in the future, a one-point change in growth or discount rate can move the answer by a quarter.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Eton Pharmaceuticals, Inc. (ETON) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ETON/free-cash-flow
Underlying data: the company's filings with the SEC and Yahoo Finance.